Stroke trials in Germany
46 of 82 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleStroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
- Where
- Berlin, Dresden, Halle (saale), Tuebingen, Wermsdorf
- Age
- 18 years and over
- People
- 2,628 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07430956 · EU 2025-521618-25-00 - Phase 3Taking peopleRecombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
- Where
- Augsburg, Berlin, Erlangen, Frankfurt am Main, Hamburg, Heidelberg, Tübingen
- Age
- 18 years to 80 years
- People
- 350 worldwide
- Run by
- Joseph Broderick, MD
See details and how to joinNCT07227246 - No phaseTaking peopleEarly Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy
- Where
- Berlin, Bonn, Göttingen, Hamburg, Heidelberg, Leipzig, Lübeck, Mannheim, Tübingen
- Age
- 18 years and over
- People
- 482 worldwide
- Run by
- Insel Gruppe AG, University Hospital Bern
See details and how to joinNCT05976685 - No phaseTaking peopleA Pivotal Study Evaluating Safety and Effectiveness of Adaptative Tip Catheter in Patients With Acute Ischemic Stroke
- Where
- Heidelberg, Kiel, Mainz, Solingen
- Age
- 18 years to 90 years
- People
- 74 worldwide
- Run by
- Neuravi Limited
See details and how to joinNCT07367100 - Phase 3Taking peopleStroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
- Where
- Altenburg, Bonn, Dresden, Essen, Hagen, Halle (saale), Kaiserslautern, Minden, Tuebingen, Wermsdorf
- Age
- 18 years and over
- People
- 15,364 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07626411 · EU 2025-521617-97-00 - Phase 3Taking peopleA Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
- Where
- Essen, Essen, Ruhr, Goch, Hamburg, Köln, Oldenburg in Holstein, Stuhr
- Age
- 50 years and over
- People
- 7,140 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07241390 · EU 2025-523123-22-00 - No phaseNot yet taking people in GermanyEvaluation of iNstroke Aspiration Catheters for Thrombectomy: a Multi-center Prospective Study
- Where
- Bremen, Cologne, Dortmund, Hamburg, Nuremberg
- Age
- 18 years and over
- People
- 160 worldwide
- Run by
- iVascular S.L.U.
See details and how to joinNCT07376447 - Phase 3Taking peopleKHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases
- Where
- München
- Age
- 18 years and over
- People
- 220 worldwide
- Run by
- Khondrion BV
See details and how to joinNCT06451757 - Phase 2Taking peopleLocal Tenecteplase ApplicatiOn subsequent to endovasCular Recanalization in Anterior CircuLation Stroke - the LOCAL trial
- Where
- Aachen, Augsburg, Bielefeld, Bonn, Dortmund, Erfurt, Essen, Flensburg, Freiburg im Breisgau, Heidelberg, Ludwigsburg, Mainz, Minden, Nuremberg, Wuerzburg
- Age
- 18 years and over
- People
- 380
- Run by
- Universitaetsklinikum Heidelberg AöR
See details and how to join2024-516544-26-00 · EU 2024-516544-26-00 - Phase 3Taking peopleLow Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
- Where
- Essen
- Age
- 18 years and over
- People
- 6,150 worldwide
- Run by
- Population Health Research Institute
See details and how to joinNCT04774159 - No phaseTaking peopleComparing Two PFO Closure Devices in Adults With Previous Stroke or TIA
- Where
- Bad Oeynhausen
- Age
- 18 years to 65 years
- People
- 1,260
- Run by
- Giuseppe Tarantini
See details and how to joinNCT07380490 - Phase 4Taking peopleSafety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake
- Where
- Bad Neustadt a.d.Saale, Bochum, Bottrop, Erfurt, Frankfurt, Freiburg, Gießen, Göttingen, Hamburg, Heidelberg, Homburg, Jena, Karlsbad, Kassel, Leipzig, Lübeck, Ludwigshafen Am Rhein, München, Sande, Schleswig, Tübingen, Ulm
- Age
- 18 years and over
- People
- 906 worldwide
- Run by
- Insel Gruppe AG, University Hospital Bern
See details and how to joinNCT06571149 · EU 2024-515561-34-01 - Phase 2/3Taking peopleOptimizing Reperfusion to Improve Outcomes and Neurologic Function (ORION)
- Where
- Altenburg, Frankfurt Am Main, Leipzig, Luebeck, Trier
- Age
- 18 years and over
- People
- 210 worldwide
- Run by
- Corxel Pharmaceuticals Co. Ltd.
See details and how to join2024-519521-37-01 · EU 2024-519521-37-01 - No phaseTaking peopleWE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)
- Where
- Bonn, Kassel, Lübeck, Munich
- Age
- 18 years and over
- People
- 594 worldwide
- Run by
- Philips Clinical & Medical Affairs Global
See details and how to joinNCT04701684 - Phase 3Taking peopleThrombolysis with Tenecteplase for Acute Ischemic Stroke in Patients taking Direct Oral Anticoagulants
- Where
- Aachen, Altenburg, Asbach, Aschaffenburg, Augsburg, Berlin, Bochum, Bonn, Bremen, Chemnitz, Dortmund, Dresden, Duesseldorf, Erlangen, Frankfurt Am Main, Halle (saale), Hamburg, Hanover, Hoexter, Kiel, Leipzig, Luebeck, Lueneburg, Magdeburg, Mainz, Mannheim, Marburg, Mettmann, Minden, Moenchengladbach, Muenster, Munich, Nuremberg, Oldenburg, Osnabrueck, Potsdam, Regensburg, Stuttgart, Wiesbaden, Wuerzburg
- Age
- 18 years and over
- People
- 668
- Run by
- University Medical Center Hamburg-Eppendorf
See details and how to join2025-521762-99-00 · EU 2025-521762-99-00 - Phase 3Not yet taking people in GermanyPost-intervention dual antiplatelet therapy for mild stroke
- Where
- Altenburg, Augsburg, Bad Neustadt A.D.Saale, Berlin, Bonn, Cottbus, Dresden, Emden, Essen, Frankfurt Am Main, Giessen, Goettingen, Halle (Saale), Hamburg, Heidelberg, Herne, Leipzig, Luebeck, Mannheim, Marburg, Minden, Munich, Osnabrueck, Tuebingen, Ulm, Wuerzburg
- Age
- 18 years and over
- People
- 2,126
- Run by
- Technische Universitaet Dresden
See details and how to join2026-525681-22-00 · EU 2026-525681-22-00 - Phase 2/3Taking peopleOptimizing Reperfusion to Improve Outcomes and Neurologic Function
- Where
- Altenburg, Frankfurt, Leipzig, Lübeck, Trier
- Age
- 18 years to 90 years
- People
- 740 worldwide
- Run by
- Corxel Pharmaceuticals
See details and how to joinNCT06990867 - No phaseTaking peopleThe Fourth Left Atrial Appendage Occlusion Study
- Where
- Bad Oeynhausen, Berlin, Cologne, Darmstadt, Erfurt, Frankfurt am Main, Frankfurt Am Main, Hamburg, Heidelberg, Kaiserslautern, Karlsruhe, Leipzig, Lübeck, Rostock, Zwickau
- Age
- 18 years and over
- People
- 4,000 worldwide
- Run by
- Hamilton Health Sciences Corporation
See details and how to joinNCT05963698 - Phase 3Taking peopleAssess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
- Where
- Altenburg, Bad Neustadt A.D.Saale, Berlin, Erlangen, Essen, Goettingen, Hamburg, Ludwigshafen Am Rhein, Luebeck, Minden, Munich, Recklinghausen, Tuebingen
- Age
- 18 years to 80 years
- People
- 514 worldwide
- Run by
- Pharmazz, Inc.
See details and how to joinNCT05691244 · EU 2024-519551-29-00 - Phase 2Taking peopleReduction of SystemiC Inflammation After Ischemic Stroke by Intravenous DNase Administration (ReSCInD)
- Where
- Berlin, Hamburg, Hanover, Munich
- Age
- 18 years and over
- People
- 36
- Run by
- Ludwig-Maximilians - University of Munich
See details and how to joinNCT05880524 · EU 2024-516701-22-00 - Phase 2Taking peopleA Study of TAK-755 in Adults With Acute Ischemic Stroke
- Where
- Berlin, Dresden, Frankfurt am Main, Göttingen, Heidelberg, Potsdam, Tübingen
- Age
- 18 years and over
- People
- 222 worldwide
- Run by
- Takeda
See details and how to joinNCT07392450 - Phase 1/2Taking peopleA Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.
- Where
- Bonn, Hamburg, Tuebingen
- Age
- 18 years to 70 years
- People
- 240 worldwide
- Run by
- Ipsen
See details and how to joinNCT04752774 · EU 2023-507202-14-00 - Phase 2Not yet taking people in GermanyPhase 2 Trial of TAK-755 for Acute Ischemic Stroke
- Where
- Goettingen, Heidelberg, Tuebingen
- Age
- 18 years and over
- People
- 67 worldwide
- Run by
- Takeda Development Center Americas Inc.
See details and how to join2025-522734-31-00 · EU 2025-522734-31-00 - Phase 3Taking peopleAnticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
- Where
- Aachen, Bad Nauheim, Berlin, Bonn, Duesseldorf, Frankfurt Am Main, Freiburg im Breisgau, Halle (Saale), Hamburg, Jena, Leipzig, Magdeburg, Munich, Oldenburg, Trier
- Age
- 18 years and over
- People
- 3,200 worldwide
- Run by
- Icahn School of Medicine at Mount Sinai
See details and how to joinNCT04045665 · EU 2024-515924-35-00 - Phase 3Taking peopleEarly Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute STROKE
- Where
- Bad Neustadt A.D.Saale, Berlin, Bielefeld, Bonn, Cologne, Dresden, Erlangen, Essen, Frankfurt Am Main, Giessen, Halle (Saale), Hamburg, Hanover, Heidelberg, Kiel, Leipzig, Luebeck, Lueneburg, Mannheim, Marburg, Muenster, Munich, Neumuenster, Tuebingen, Ulm, Wuerzburg
- Age
- 18 years and over
- People
- 1,746 worldwide
- Run by
- Universitätsklinikum Hamburg-Eppendorf
See details and how to joinNCT05293080 · EU 2025-521260-35-00